Physician

Max Ray Johnson, MD

According to 2025 Medicare claims, Max Johnson, MD (NPI: 1679559975) practices ophthalmology in the Fargo, ND-MN market, with the plurality of this provider's patient population coming from Cass, ND. This provider's primary affiliated billing organization is RETINA CONSULTANTS, LTD (NPI: 1972589182; TIN: 450408552) and primary practice location at 58104-4556.

Johnson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 874 traditional Medicare patients, billed 40,868 HCPCS/CPT codes, and received $2,833,902 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 288 prescription claims across 83 beneficiaries totaling $18,064 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 3 records totaling $264. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $4,875,534 to $2,833,902. Similarly, Part D prescription costs have declined steadily, from $39,262 to $18,064. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.4M$4.9M2015 Medicare payment: $4,875,534 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,812,904 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,835,197 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,105,708 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,515,794 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,020,111 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,329,846 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,482,094 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,830,832 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,833,902 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,09220,364$4,875,534
20161,06918,881$4,812,904
20171,03315,390$3,835,197
20181,03813,680$3,105,708
20191,16517,523$3,515,794
20201,01714,433$3,020,111
20211,09714,348$3,329,846
202295416,428$3,482,094
202384229,347$2,830,832
202487440,868$2,833,902

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$20K$40K2015 Drug cost: $39,262 (USD; Tot_Drug_Cst)2016 Drug cost: $38,355 (USD; Tot_Drug_Cst)2017 Drug cost: $23,181 (USD; Tot_Drug_Cst)2018 Drug cost: $29,429 (USD; Tot_Drug_Cst)2019 Drug cost: $33,149 (USD; Tot_Drug_Cst)2020 Drug cost: $40,074 (USD; Tot_Drug_Cst)2021 Drug cost: $32,447 (USD; Tot_Drug_Cst)2022 Drug cost: $23,412 (USD; Tot_Drug_Cst)2023 Drug cost: $24,909 (USD; Tot_Drug_Cst)2024 Drug cost: $18,064 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015132524$39,262
2016122628$38,355
2017118470$23,181
2018116478$29,429
2019119549$33,149
2020129686$40,074
2021165744$32,447
2022117374$23,412
202395345$24,909
202483288$18,064

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2132,190$656
67028Injection of drug into eye4091,466$101
92014Established patient complete exam of visual system6941,059$94
92134Imaging of retina8162,137$31
92250Photography of the retina233317$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium13336$2,804
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol18438$2,296
LatanoprostLatanoprost783,022$1,326
Prednisolone AcetatePrednisolone Acetate251,196$1,231
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha41956$487

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$264Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Max Ray Johnson, MD?

Tedicare shows public-source Medicare data for Max Ray Johnson, MD (NPI 1679559975), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Max Ray Johnson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Max Ray Johnson, MD?

Max Ray Johnson, MD is linked to RETINA CONSULTANTS, LTD (billing NPI 1972589182) in the available physician profile data.

Does Max Ray Johnson, MD have Open Payments data?

Max Ray Johnson, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.